About Recro

Recro (NASDAQ: REPH) is a revenue generating Contract Development and Manufacturing Organization (CDMO) with capabilities from early feasibility and product development solutions through to commercial manufacturing.

Recro owns and operates a 97,000 SF DEA Licensed facility in Gainesville, GA that manufactures commercial cGMP products for companies in the U.S. and abroad. In addition, Recro leases a 24,000 SF also located in Gainesville, GA that provides product development services for oral dose forms with complexities as well as for high potency products of certain categories.